EZH2 has been shown to exert diverse regulatory roles in GBM, modulating pathways in tumor initiation/self-renewal, differentiation, cell cycle progression, metabolism, immunogenicity, and invasiveness. The gene discussed is EZH2; the disease is neoplasm.